Disc Medicine Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,355	1,394	86	125	171	-
Market Cap Growth	281.71%	1517.95%	-31.31%	-26.58%	-	-
Enterprise Value	1,006	1,036	-107	39	188	7
PE Ratio	-	-18.24	-1.84	-3.49	-4.18	-
PB Ratio	3.98	4.04	0.49	-1.95	-7.82	-
P/FCF Ratio	-21.42	-18.96	-2.03	-4.55	-5.22	-
P/OCF Ratio	-21.46	-18.98	-2.04	-4.56	-5.22	-
EV/EBITDA Ratio	-14.94	-13.64	2.30	-1.09	-5.58	-0.16
EV/EBIT Ratio	-14.85	-13.57	2.29	-1.09	-5.53	-0.16
EV/FCF Ratio	-16.68	-14.09	2.53	-1.42	-5.74	-0.17
Debt / Equity Ratio	0.01	0.01	0.01	-0.03	-0.99	-0.14
Debt / EBITDA Ratio	-0.03	-0.03	-0.03	-0.05	-0.64	-0.24
Debt / FCF Ratio	-0.03	-0.03	-0.03	-0.06	-0.66	-0.26
Quick Ratio	23.07	16.81	8.62	6.56	0.18	0.37
Current Ratio	23.70	17.06	8.79	6.74	0.20	0.58
Interest Coverage	-	-	-	-	-4.98	-117.29
Return on Equity (ROE)	-22.80%	-23.40%	-37.50%	-35.50%	88.10%	-
Return on Assets (ROA)	-21.70%	-22.30%	-34.40%	-23.60%	-564.70%	-
Return on Capital (ROIC)	-28.66%	-26.24%	-26.68%	49.45%	15402.71%	67.71%
Earnings Yield	-5.98%	-5.48%	-54.34%	-28.67%	-23.90%	-
FCF Yield	-5.33%	-5.27%	-49.20%	-22.00%	-19.15%	-
Buyback Yield / Dilution	-30.89%	-2046.81%	-18.34%	41.89%	-192.28%	-
Total Shareholder Return	-30.89%	-2046.81%	-18.34%	41.89%	-192.28%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).